Skip to content
Riskpilot
← Back to search
Sign in
Sign in
Get full access
Ederagen Pharma AS
AS
Active
Org 937251750
Litleåsvegen 13, 5132
Nyborg
Research and experimental development on natural sciences and engineering
·
NACE 7210
Est. 2026 · <1 year old
— employees
Monitor
Share
Norway
/
Companies
/
Research and experimental development on natural sciences and engineering
/
Ederagen Pharma AS
Overview
Financials
People & ownership
Related companies
Loading company…
People & ownership
Management
Actively employed in the business
Name
Role
Member since
Current (1)
KE
Knut Eirik Andersen
Chief Executive Officer
Chief Executive Officer
2026
Board of directors
Non-executive oversight
Name
Role
Member since
Current (3)
TH
Torfinn Hynnekleiv
Board of Directors
Board of Directors
2026
KE
Knut Eirik Andersen
Board of Directors
Board of Directors
2026
JR
Jan Raa
Chairman
Chairman
2026
Shareholders
As of last annual report
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
More on Ederagen Pharma AS
Overview →
Headline figures, risk assessment and company summary
Financials & key figures →
Revenue, EBITDA, balance sheet and 5-year trend
Related companies →
Corporate hierarchy, parent and subsidiary network
